The following are recent developments in Cell and Gene Therapy, from the latest issue of Cell and Gene Therapy Business Outlook Adicet Bio, based in Boston, MA, reported positive interim data from its Phase I dose escalation study of ADI-001, a gamma delta CAR T-cell therapy targeting CD20 for the treatment of B-cell non-Hodgkin’s lymphoma. […]
We keep saying it, but that is only because it remains true: China continues to be an untapped market for IVD manufacturers. It’s certainly not out of a desire to follow the crowd. As China’s rate of growth has slowed, we’ve noted that. Yet based on our global market analysis, the IVD market there remains […]
In a hybrid virtual and in-person meeting based in Atlanta, GA this year, the American Association of Clinical Chemistry met to share insights in laboratory medicine. The event coincides with the Clinical Lab Expo, which is an important showcase for IVD vendors demonstrating new products and conducting strategic presentations and commentary. About 7,500 lab professionals […]
Kalorama Information, specialists in market research data in the in vitro diagnostics market since 2001, has now published its latest (14th) edition of their comprehensive market report. The market for IVD products including instruments and reagents is $117 billion dollars. Kalorama’s 1,500 + page report is used by top companies in the industry and by prospective entrants, investors and […]
The market for DNA-based tests used for clinical diagnostic purposes has exceeded previous forecasting, due to the COVID-19 crisis. Mid 2019, Kalorama Information’s report projected the market size (all DNA-based tests, revenues to IVD companies) would reach 10.1 billion. We also estimated cancer would be the driver. Instead, Kalorama now projects that market to be […]
Diagnostic testing companies should do a better job of turning around biomarker test results for lung cancer patients, according to a survey reported at the American Society of Clinical Oncology (ASCO) annual meeting on June 4. Out of 170 clinicians polled, the vast majority (98%) said that they felt it was important to get biomarker […]
The American Association for Clinical Chemistry (AACC) released guidance on lab testing for acute kidney injury (AKI) patients that proposes new diagnostic thresholds for whether a patient has AKI with creatinine testing. One of the major recommendations is to propose that clinicians use the 20/20 AACC acute kidney injury criteria to determine whether a patient […]
There are currently 76.1 billion in vitro diagnostics (IVD) procedures annually worldwide. Global IVD procedure volumes are forecast to grow by several billion more through 2025, as revealed in IVD Procedure Volumes 2020-2025: Immunoassays, POC, Chemistry, Molecular, Microbiology and Other Tests, a recent report by Kalorama Information. IVD procedures range from glucose to procedures including […]
Modern developments in cell and gene therapy products are transforming the treatment of cancers and genetic diseases, and in the process they have helped create a multi-billion dollar global industry that is poised to more than double over the next ten years, according to 2020 estimates by leading medical market research firm Kalorama Information as […]
A recent deal in the news cements the viability of the respiratory segment and the use of small molecular systems to test for them. First introduced in 2013, PCR and other NAAT-based molecular systems have become a central part of testing for ailments such as flu, strep, RSV and COVID-19. They remain in competition with […]
